Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma
Figure 6
Dkk-3 modulates S100A4, Met, and downstream phosphorylated MAPK and AKT. (a) and (b) Western blot analysis demonstrating expressions of S100A4, Met, and phosphorylated/non-phosphorylated MAPK and AKT in Dkk-3 and control vector transfected SaOS-2 cells.
